A separate investigation by Chen et al. (160) highlighted the therapeutic efficacy of JWQZG in the treatment of MASLD, demonstrating its regulatory influence on the insulin signaling pathway. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.